• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

MOBILion Partners with BOKU Vienna to Introduce High-Resolution Ion Mobility in Europe

Share:

January 9, 2024

MOBILion Systems partners with The University of Natural Resources and Life Sciences, Vienna (BOKU) to introduce the MOBIE® instrument in Europe. This collaboration aims to advance research in pharma, biopharma, and environmental testing by offering enhanced separation capabilities. The MOBIE system accelerates analyses, delivering cleaner spectra and increased throughput, promising accurate identifications 5 to 60 times faster than conventional methods. This partnership kick-starts MOBILion’s limited European launch, supporting demos and training for customers.

MOBILion Systems, Inc., a life science tools and instrumentation company, has partnered with The University of Natural Resources and Life Sciences, Vienna (BOKU), an Agilent Partner Lab, to install its first MOBIE® instrument in Europe. This collective effort will allow BOKU to advance their cutting-edge research which is of great interest to the European pharma, biopharma, environmental testing, and academic communities who will also benefit from gaining access to MOBILion’s next generation separation platform.

The MOBIE system enhances and accelerates workflows for a wide variety of analyte classes, providing more accurate identifications and analysis 5 to 60 times faster than conventional methods. The additional dimension of separation simplifies downstream data analysis by producing cleaner spectra and increases throughput while delivering unprecedented reproducibility. The MOBIE platform is available as a field upgrade or a full system, and is compatible with Agilent 6545, 6545XT, and 6546 Q-TOF platforms.

“We are excited to be working with BOKU on our first installation of the MOBIE product as the kick-off of our limited launch in Europe. Leveraging their capabilities and expertise allows us to provide access and support to our European customers with demos and instrument familiarization training,” said Melissa Sherman, MOBILion CEO.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

BOKU’s research objectives include investigating rapid separations of molecular and isomer systems and rigorously evaluating MOBIE’s value across diverse fields ranging from biotechnology to food and environmental studies where the enhanced separation power of the MOBIE platform over existing technologies can be harnessed.

Source: Bio Space

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Veeva Acquires Physicians WorldVeeva Acquires Physicians World
  • Europe’s Largest Initiative to Accelerate Therapy Development for Covid-19 LaunchedEurope’s Largest Initiative to Accelerate Therapy Development for Covid-19 Launched
  • Amare Global Announces Acquisition of Kyäni, Inc.Amare Global Announces Acquisition of Kyäni, Inc.
  • The Supreme Cannabis Company, Inc. Announces $90 Million Bought Deal Financing of Convertible DebenturesThe Supreme Cannabis Company, Inc. Announces $90 Million Bought Deal Financing of Convertible Debentures
  • Herbal Medicines Market Growth Insights, Impact of COVID-19 Analysis, Applications, Sales Statistics and Industry Trends By 2027 | Bio-Botanica , Blackmores, Dabur , Guangzhou PharmaHerbal Medicines Market Growth Insights, Impact of COVID-19 Analysis, Applications, Sales Statistics and Industry Trends By 2027 | Bio-Botanica , Blackmores, Dabur , Guangzhou Pharma
  • RealSelf Acquires Tajmeeli.com to serve Arabic-Speaking Medical Aesthetics MarketRealSelf Acquires Tajmeeli.com to serve Arabic-Speaking Medical Aesthetics Market
  • Healthgrades Acquires Consumer & Physician Engagement Company EvariantHealthgrades Acquires Consumer & Physician Engagement Company Evariant
  • Ani Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.Ani Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications